ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3018

The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice

Yuichi Maeda1, Masato Matsushita2, Masashi Narazaki3, Yukihiko Saeki4,5, Atsushi Kumanogoh6 and Kiyoshi Takeda7, 1Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 2Rheumatology, Osaka Minami Medical Center, Osaka, Japan, 3Osaka University Graduate School of Medicine, Suita, Japan, 4Dept of Clinical research, Osaka-Minami Medical Ctr, Osaka, Japan, 5Dept of Clinical Research, Osaka-Minami Medical Center, Kawachinagano City, Japan, 6Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 7Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Suita, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Animal models, microbiome and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Although various genetic factors have been implicated in susceptibility to rheumatoid arthritis (RA), environmental factors including smoking, periodontal disease and hormones are also necessary for the disease manifestations. We speculate that gut microbiota is one such environmental factor that may be correlated with the development of RA. Previous reports have demonstrated that RA patients have altered composition of gut microbiota. However, it remains unclear whether the altered composition of intestinal microbiota observed in RA patients causes the disease onset.

Methods: We first examined whether RA patients have particular patterns of microbiota. All the patients were diagnosed according to the American College of Rheumatology/European League Against Rheumatism 2010 classification criteria for RA. We collected human fecal samples from 17 untreated new-onset RA patients (disease duration 1.0±0.7 years, mean±SD) and 13 healthy volunteers to investigate the microbiota by 16S rRNA-based deep sequence technique. We further analyzed the correlation between bacterial counts of intestinal microbiota and disease activity in 50 treated RA patients (disease duration 9.6±9.0 years, mean±SD) by quantitative reverse transcription PCR (RT-qPCR) method. We also inoculated human fecal samples from new-onset RA patients or healthy controls into germ free SKG mice (intestinal microbiota-humanized mice) and analyzed for the severity of arthritis and immune responses. We next evaluated whether Prevotella copri (P. copri) has an ability to induce Th17-related cytokines in vitro. Bone marrow-derived DCs were stimulated with intestinal bacteria and analyzed for the production of Th17-related cytokines. Finally, we inoculated P. copri into germ free SKG mice and analyzed severity of arthritis.

Results: Six out of 17 new-onset RA patients showed high abundance of Prevotella. Especially, P. copri was dominant OTU in the RA patients. None of the healthy controls harbored increased abundance of Prevotella. The bacterial counts of Prevotella were positively correlated with the disease activity of treated 50 RA patients (r = 0.36, P<0.01). SKG mice harboring Prevotella-dominated microbiota from new-onset RA patients (RA-SKG mice) showed severe arthritis in the presence of zymosan injection. Increased number of Th17 cells in the regional lymph nodes and large intestine was observed in RA-SKG mice. P. copri induced high production of IL-6 and IL-23, indicating that P.copri has an ability to enhance Th17-biased immune responses. Mono-colonization of P. copri into germ free SKG mice also showed arthritis.

Conclusion: Prevotella–dominated gut microbiota may contribute to the development of arthritis both in human RA patients and SKG mice.


Disclosure: Y. Maeda, None; M. Matsushita, None; M. Narazaki, None; Y. Saeki, None; A. Kumanogoh, None; K. Takeda, None.

To cite this abstract in AMA style:

Maeda Y, Matsushita M, Narazaki M, Saeki Y, Kumanogoh A, Takeda K. The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-analysis-of-severity-of-arthritis-in-the-intestinal-microbiota-humanized-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-analysis-of-severity-of-arthritis-in-the-intestinal-microbiota-humanized-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology